NeuroMind is a clinical decision support tool for neurosurgeons and neurologists, providing rapid access to medical scoring and classification systems on iOS and Android.
The App DNA
What makes this app unique?
It removes the cognitive friction of manual calculation during bedside patient assessment, serving as a reliable ready-reckoner for clinical practice.
For Neurosurgeons and neurologists requiring quick access to clinical decision-making tools.
What does it look like?
Key features
Rapid access to medical scoring and classification frameworks for neurosurgery and neurology.
Educational content portal linked within the application interface.
How much does it cost?
The app operates as a free, utility-focused tool for medical professionals with no visible subscription or pay-gate.
Velocity
Dormant developmentopaqueShow more...
NeuroMind has been inactive for 1,373 days, indicating a complete cessation of development. There have been no feature updates, bug fixes, or operational changes in over three years. The project appears to be abandoned by its publisher.
Who built it?
User Sentiment
What do users think recently?
The recent review mood reads excited. Users appreciate medical professionals value the quick navigation of neurological scores for bedside patient assessment and stratification and the application serves as a reliable reference for neurosurgeons and clinicians managing neurological patients.
How are ratings & reviews evolving?
What users say, by theme
- Medical professionals value the quick navigation of neurological scores for bedside patient assessment and stratification
- The application serves as a reliable reference for neurosurgeons and clinicians managing neurological patients
- Mandatory access codes without clear instructions prevent users from launching the application after the latest update
43 of 43 recent reviews analyzed · high confidence · Excited overall
Read the full review analysisUnlock 2 more frustration themes and 2 user requests, each backed by review evidence.
Access the full report for freeCompetition
Competitive landscape for NeuroMind
How's the Medical market?
NeuroMind occupies a niche utility space in the Medical category, holding a 4.33 rating on iOS and 4.14 on Android. The lack of updates since late 2022 suggests the app is currently in maintenance mode rather than active growth.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for NeuroMind
Where is it heading?
The medical reference market is shifting toward high-frequency update models that ensure clinical accuracy and OS compatibility. NeuroMind's lack of development since 2022 leaves it exposed to newer, more reliable competitors, and the current onboarding friction will likely continue to compress its active user base.
- The 45-month release gap indicates the app is in maintenance mode, which increases the risk of abandonment as OS requirements evolve.
- Mandatory access codes without instructions prevent new users from launching the app, which directly accelerates churn and negative sentiment.
The SWOT
- Category authority as a clinical reference tool builds a defensible brand position among medical professionals
- Adding a traumatic brain injury prognosis calculator would directly address the top-requested utility gap
Next best moves
Remove the mandatory access code requirement because it is the primary barrier to app entry → restore user access
+ 1 more prioritized moveThe counter-intuitive read
NeuroMind's lack of a monetization model is its primary risk…
Read the full takeBottom line
NeuroMind retains a core professional user base through its specialized scoring utility, but the current access-code friction and technical instability threaten its clinical reliability. Resolving the onboarding barrier would immediately restore the tool's utility for its target audience.
Unlock 2 critical frictions, 1 market threat, 1 more prioritized move and the analyst’s take.
Access the full report for freeSources
Report last updated